Skip to main content
Erschienen in: Cardiovascular Toxicology 1/2019

24.08.2018

Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes

verfasst von: Hyo-In Choi, Jung Ae Hong, Min-Seok Kim, Sang Eun Lee, Sung-Ho Jung, Pil Whan Yoon, Joon Seon Song, Jae-Joong Kim

Erschienen in: Cardiovascular Toxicology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Cobalt-induced cardiomyopathy is a well-known but uncommon disease, and the physician must maintain a high index of suspicion in order to make a timely diagnosis. We report two patients with cobalt-induced cardiomyopathy. Both patients developed progressively worsening symptoms of cobalt toxicity following revision of a fractured ceramic-on-ceramic total hip replacement to a metal-on-polyethylene bearing. In both patients, echocardiography showed LV hypertrophy, biventricular systolic dysfunction, and a large amount of pericardial effusion. Due to decompensated heart failure, both patients were initially considered candidates for heart transplantation. One patient was diagnosed with cobalt-induced cardiomyopathy before transplantation. He received cobalt chelation therapy and revision surgery, which led to complete recovery of heart function. In the other patient, the diagnosis was not made until the time of heart transplantation. The gross examination of the explanted heart revealed typical features of cobalt cardiotoxicity, which was then diagnosed as cobalt-induced cardiomyopathy. These cases emphasise the importance of early diagnosis and prompt treatment of cobalt intoxication.
Literatur
1.
Zurück zum Zitat Gilbert, C. J., et al. (2013). Hip pain and heart failure: The missing link. Canadian Journal of Cardiology, 29(5), 639e1–e2.CrossRef Gilbert, C. J., et al. (2013). Hip pain and heart failure: The missing link. Canadian Journal of Cardiology, 29(5), 639e1–e2.CrossRef
2.
Zurück zum Zitat Machado, C., Appelbe, A., & Wood, R. (2012). Arthroprosthetic cobaltism and cardiomyopathy. Heart, Lung and Circulation, 21(11), 759–760.CrossRefPubMed Machado, C., Appelbe, A., & Wood, R. (2012). Arthroprosthetic cobaltism and cardiomyopathy. Heart, Lung and Circulation, 21(11), 759–760.CrossRefPubMed
3.
Zurück zum Zitat van Lingen, C. P., et al. (2013). Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels. Hip International, 23(5), 441–444.CrossRefPubMed van Lingen, C. P., et al. (2013). Clinical manifestations in ten patients with asymptomatic metal-on-metal hip arthroplasty with very high cobalt levels. Hip International, 23(5), 441–444.CrossRefPubMed
4.
Zurück zum Zitat Oldenburg, M., Wegner, R., & Baur, X. (2009). Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. The Journal of Arthroplasty, 24(5), 825 e15–e20.CrossRef Oldenburg, M., Wegner, R., & Baur, X. (2009). Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty. The Journal of Arthroplasty, 24(5), 825 e15–e20.CrossRef
5.
Zurück zum Zitat Cheung, A. C., et al. (2016). Systemic cobalt toxicity from total hip arthroplasties: Review of a rare condition Part 1—History, mechanism, measurements, and pathophysiology. The Bone & Joint Journal, 98-b(1), 6–13.CrossRef Cheung, A. C., et al. (2016). Systemic cobalt toxicity from total hip arthroplasties: Review of a rare condition Part 1—History, mechanism, measurements, and pathophysiology. The Bone & Joint Journal, 98-b(1), 6–13.CrossRef
6.
Zurück zum Zitat Gessner, B. D., et al. (2015). A systematic review of systemic cobaltism after wear or corrosion of chrome-cobalt hip implants. Journal of Patient Safety, 0, 1–8CrossRef Gessner, B. D., et al. (2015). A systematic review of systemic cobaltism after wear or corrosion of chrome-cobalt hip implants. Journal of Patient Safety, 0, 1–8CrossRef
7.
Zurück zum Zitat Tower, S. S. (2010). Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. The Journal of Bone and Joint Surgery, 92(17), 2847–2851.CrossRefPubMed Tower, S. S. (2010). Arthroprosthetic cobaltism: Neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: A case report. The Journal of Bone and Joint Surgery, 92(17), 2847–2851.CrossRefPubMed
8.
Zurück zum Zitat Catalani, S., et al. (2012). Neurotoxicity of cobalt. Human & Experimental Toxicology, 31(5), 421–437.CrossRef Catalani, S., et al. (2012). Neurotoxicity of cobalt. Human & Experimental Toxicology, 31(5), 421–437.CrossRef
9.
Zurück zum Zitat Mosier, B. A., Maynard, L., Sotereanos, N. G., Sewecke, J. J. (2016). Progressive cardiomyopathy in a patient with elevated cobalt ion levels and bilateral metal-on-metal hip arthroplasties. The American Journal of Orthopedics, 45(3), E132–E135.PubMed Mosier, B. A., Maynard, L., Sotereanos, N. G., Sewecke, J. J. (2016). Progressive cardiomyopathy in a patient with elevated cobalt ion levels and bilateral metal-on-metal hip arthroplasties. The American Journal of Orthopedics, 45(3), E132–E135.PubMed
10.
Zurück zum Zitat Zywiel, M. G., et al. (2013). Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. The Bone & Joint Journal, 95(1), 31–37.CrossRef Zywiel, M. G., et al. (2013). Fatal cardiomyopathy after revision total hip replacement for fracture of a ceramic liner. The Bone & Joint Journal, 95(1), 31–37.CrossRef
11.
12.
Zurück zum Zitat Samar, H. Y., et al. (2015). Novel use of cardiac magnetic resonance imaging for the diagnosis of cobalt cardiomyopathy. JACC Cardiovasc Imaging, 8(10), 1231–1232.CrossRefPubMed Samar, H. Y., et al. (2015). Novel use of cardiac magnetic resonance imaging for the diagnosis of cobalt cardiomyopathy. JACC Cardiovasc Imaging, 8(10), 1231–1232.CrossRefPubMed
13.
Zurück zum Zitat Kempf, I., & Semlitsch, M. (1990). Massive wear of a steel ball head by ceramic fragments in the polyethylene acetabular cup after revision of a total hip prosthesis with fractured ceramic ball. Archives of Orthopaedic and Trauma Surgery, 109(5), 284–287.CrossRefPubMed Kempf, I., & Semlitsch, M. (1990). Massive wear of a steel ball head by ceramic fragments in the polyethylene acetabular cup after revision of a total hip prosthesis with fractured ceramic ball. Archives of Orthopaedic and Trauma Surgery, 109(5), 284–287.CrossRefPubMed
14.
Zurück zum Zitat Morin, Y., Tetu, A., & Mercier, G. (1971). Cobalt cardiomyopathy: Clinical aspects. British Heart Journal, 33(p. Suppl), 175–178.CrossRefPubMedCentral Morin, Y., Tetu, A., & Mercier, G. (1971). Cobalt cardiomyopathy: Clinical aspects. British Heart Journal, 33(p. Suppl), 175–178.CrossRefPubMedCentral
15.
Zurück zum Zitat Morin, Y., Tetu, A., & Mercier, G. (1969). Quebec beer-drinkers’ cardiomyopathy: Clinical and hemodynamic aspects. Annals of the New York Academy of Sciences, 156(1), 566–576.CrossRefPubMed Morin, Y., Tetu, A., & Mercier, G. (1969). Quebec beer-drinkers’ cardiomyopathy: Clinical and hemodynamic aspects. Annals of the New York Academy of Sciences, 156(1), 566–576.CrossRefPubMed
16.
Zurück zum Zitat Alexander, C. S. (1972). Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. The American Journal of Medicine, 53(4), 395–417.CrossRefPubMed Alexander, C. S. (1972). Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases. The American Journal of Medicine, 53(4), 395–417.CrossRefPubMed
17.
Zurück zum Zitat Tilney, R., Burg, M. R., & Sammut, M. A., (2017). Cobalt cardiomyopathy secondary to hip arthroplasty: An increasingly prevalent problem. Case Reports in Cardiology, 2017, 5434571.CrossRefPubMedPubMedCentral Tilney, R., Burg, M. R., & Sammut, M. A., (2017). Cobalt cardiomyopathy secondary to hip arthroplasty: An increasingly prevalent problem. Case Reports in Cardiology, 2017, 5434571.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Pandit, H., et al. (2008). Pseudotumours associated with metal-on-metal hip resurfacings. The Journal of Bone and Joint Surgery British, 90(7), 847–851.CrossRef Pandit, H., et al. (2008). Pseudotumours associated with metal-on-metal hip resurfacings. The Journal of Bone and Joint Surgery British, 90(7), 847–851.CrossRef
19.
Zurück zum Zitat Polyzois, I., et al. (2012). Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. Journal of Applied Toxicology, 32(4), 255–269.CrossRefPubMed Polyzois, I., et al. (2012). Local and systemic toxicity of nanoscale debris particles in total hip arthroplasty. Journal of Applied Toxicology, 32(4), 255–269.CrossRefPubMed
20.
Zurück zum Zitat Gill, H. S., et al. (2012). Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends in Molecular Medicine, 18(3), 145–155.CrossRefPubMed Gill, H. S., et al. (2012). Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends in Molecular Medicine, 18(3), 145–155.CrossRefPubMed
21.
Zurück zum Zitat Papageorgiou, I., et al. (2007). The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials, 28(19), 2946–2958.CrossRefPubMed Papageorgiou, I., et al. (2007). The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials, 28(19), 2946–2958.CrossRefPubMed
22.
Zurück zum Zitat Tower, S. (2010). Arthroprosthetic cobaltism: Identification of the at-risk patient. Alaska Medicine, 52, 28–32.PubMed Tower, S. (2010). Arthroprosthetic cobaltism: Identification of the at-risk patient. Alaska Medicine, 52, 28–32.PubMed
23.
Zurück zum Zitat Sotos, J. G., & Tower, S. S. (2013). Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviation, Space, and Environmental Medicine, 84(3), 242–245.CrossRefPubMed Sotos, J. G., & Tower, S. S. (2013). Systemic disease after hip replacement: Aeromedical implications of arthroprosthetic cobaltism. Aviation, Space, and Environmental Medicine, 84(3), 242–245.CrossRefPubMed
24.
Zurück zum Zitat Heggtveit, H. A., Grice, H. C., & Wiberg, G. S. (1970). Cobalt cardiomyopathy. Experimental basis for the human lesion. Pathologia et Microbiologia (Basel), 35(1), 110–113. Heggtveit, H. A., Grice, H. C., & Wiberg, G. S. (1970). Cobalt cardiomyopathy. Experimental basis for the human lesion. Pathologia et Microbiologia (Basel), 35(1), 110–113.
25.
Zurück zum Zitat Dingle, J. T., et al. (1962). The biological action of cobalt and other metals. II. The mechanism of the respiratory inhibition produced by cobalt in mammalian tissues. Biochimica et Biophysica Acta, 65, 34–46.CrossRefPubMed Dingle, J. T., et al. (1962). The biological action of cobalt and other metals. II. The mechanism of the respiratory inhibition produced by cobalt in mammalian tissues. Biochimica et Biophysica Acta, 65, 34–46.CrossRefPubMed
26.
Zurück zum Zitat Rona, G., (1971). Experimental aspects of cobalt cardiomyopathy. British Heart Journal, 33(Suppl), 171–174.CrossRef Rona, G., (1971). Experimental aspects of cobalt cardiomyopathy. British Heart Journal, 33(Suppl), 171–174.CrossRef
27.
Zurück zum Zitat Harrow, J. A., Das, P. K., & Dhalla, N. S. (1978). Influence of some divalent cations on heart sarcolemmal bound enzymes and calcium binding. Biochemical Pharmacology, 27(22), 2605–2609.CrossRefPubMed Harrow, J. A., Das, P. K., & Dhalla, N. S. (1978). Influence of some divalent cations on heart sarcolemmal bound enzymes and calcium binding. Biochemical Pharmacology, 27(22), 2605–2609.CrossRefPubMed
28.
Zurück zum Zitat Barceloux, D. G. (1999). Cobalt. Journal of Toxicology: Clinical Toxicology, 37(2), 201–206.PubMed Barceloux, D. G. (1999). Cobalt. Journal of Toxicology: Clinical Toxicology, 37(2), 201–206.PubMed
29.
Zurück zum Zitat Unverferth, D. V., et al. (1984). The evolution of beta-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy. Cardiovascular Research, 18(1), 44–50.CrossRefPubMed Unverferth, D. V., et al. (1984). The evolution of beta-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy. Cardiovascular Research, 18(1), 44–50.CrossRefPubMed
30.
Zurück zum Zitat Seghizzi, P., et al. (1994). Cobalt myocardiopathy. A critical review of literature. Science of the Total Environment, 150(1–3), 105–109.CrossRefPubMed Seghizzi, P., et al. (1994). Cobalt myocardiopathy. A critical review of literature. Science of the Total Environment, 150(1–3), 105–109.CrossRefPubMed
31.
Zurück zum Zitat Tabel, G. M., et al. (2006). Collagen fiber morphology determines echogenicity of myocardial scar: Implications for image interpretation. Echocardiography, 23(2), 103–107.CrossRefPubMed Tabel, G. M., et al. (2006). Collagen fiber morphology determines echogenicity of myocardial scar: Implications for image interpretation. Echocardiography, 23(2), 103–107.CrossRefPubMed
32.
Zurück zum Zitat Mohiuddin, S. M., et al. (1970). Experimental cobalt cardiomyopathy. American Heart Journal, 80(4), 532–543.CrossRefPubMed Mohiuddin, S. M., et al. (1970). Experimental cobalt cardiomyopathy. American Heart Journal, 80(4), 532–543.CrossRefPubMed
33.
Zurück zum Zitat Giampreti, A., Lonati, D., & Locatelli, C. A. (2014). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 30(4), 465.e13.CrossRefPubMed Giampreti, A., Lonati, D., & Locatelli, C. A. (2014). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 30(4), 465.e13.CrossRefPubMed
34.
Zurück zum Zitat Devlin, J. J., Schwartz, M., & Brent, J. (2013). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 29(11), 1533.e7.CrossRefPubMed Devlin, J. J., Schwartz, M., & Brent, J. (2013). Chelation in suspected prosthetic hip-associated cobalt toxicity. Canadian Journal of Cardiology, 29(11), 1533.e7.CrossRefPubMed
36.
Zurück zum Zitat Pazzaglia, U. E., et al. (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Archives of Orthopaedic and Trauma Surgery, 131(9), 1299–1308.CrossRefPubMed Pazzaglia, U. E., et al. (2011). Cobalt, chromium and molybdenum ions kinetics in the human body: Data gained from a total hip replacement with massive third body wear of the head and neuropathy by cobalt intoxication. Archives of Orthopaedic and Trauma Surgery, 131(9), 1299–1308.CrossRefPubMed
37.
Zurück zum Zitat Repo, E., et al. (2011). Capture of Co(II) from its aqueous EDTA-chelate by DTPA-modified silica gel and chitosan. Journal of Hazardous Materials, 187(1–3), 122–132.CrossRefPubMed Repo, E., et al. (2011). Capture of Co(II) from its aqueous EDTA-chelate by DTPA-modified silica gel and chitosan. Journal of Hazardous Materials, 187(1–3), 122–132.CrossRefPubMed
38.
Zurück zum Zitat Giampreti, A., et al. (2016). N-acetyl-cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: Two cases. Case Reports in Orthopedics, 2016, 8682737.CrossRefPubMedPubMedCentral Giampreti, A., et al. (2016). N-acetyl-cysteine as effective and safe chelating agent in metal-on-metal hip-implanted patients: Two cases. Case Reports in Orthopedics, 2016, 8682737.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Asapoglu, N. K., Toprak, A. B.,M. S., Koseoglu, Y., & Bayrakdar, H. (2000). Synthesis and characterization of NiFe ~ 2O ~ 4 nano-octahedrons by EDTA-assisted hydro-thermal method. Turkish Journal of Chemistry, 30, 659–666. Asapoglu, N. K., Toprak, A. B.,M. S., Koseoglu, Y., & Bayrakdar, H. (2000). Synthesis and characterization of NiFe ~ 2O ~ 4 nano-octahedrons by EDTA-assisted hydro-thermal method. Turkish Journal of Chemistry, 30, 659–666.
40.
Zurück zum Zitat Kwon, Y. M., et al. (2014). Risk stratification algorithm for management of patients with dual modular taper total hip arthroplasty: Consensus statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons and the Hip Society. The Journal of Arthroplasty, 29(11), 2060–2064.CrossRefPubMed Kwon, Y. M., et al. (2014). Risk stratification algorithm for management of patients with dual modular taper total hip arthroplasty: Consensus statement of the American Association of Hip and Knee Surgeons, the American Academy of Orthopaedic Surgeons and the Hip Society. The Journal of Arthroplasty, 29(11), 2060–2064.CrossRefPubMed
Metadaten
Titel
Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes
verfasst von
Hyo-In Choi
Jung Ae Hong
Min-Seok Kim
Sang Eun Lee
Sung-Ho Jung
Pil Whan Yoon
Joon Seon Song
Jae-Joong Kim
Publikationsdatum
24.08.2018
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 1/2019
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-018-9480-0

Weitere Artikel der Ausgabe 1/2019

Cardiovascular Toxicology 1/2019 Zur Ausgabe